VIPR1 Antikörper (Val371)
Kurzübersicht für VIPR1 Antikörper (Val371) (ABIN2892725)
Target
Alle VIPR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Val371
-
Spezifität
- Human VIPR1 / RDC1
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide around Val371 of human VIPR1 / RDC1
Type of Immunogen: Synthetic peptide
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
-
-
- VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))
-
Andere Bezeichnung
- VIPR1 / RDC1
-
Hintergrund
-
Name/Gene ID: VIPR1
Subfamily: Vasoactive intestinal polypeptide
Family: GPCR
Synonyms: VIPR1, HVR1, PACAP type II receptor, PACAP-R-2, Pvr2, RDC1, Vip receptor subtype 1, Vpac1 receptor, V1RG, VIP receptor 1, VIPR, VIRG, VPCAP1R, PACAP-R2, VAPC1, VIP and PACAP receptor 1, VPAC1R, Pacap receptor, type ii, Type II PACAP receptor, VIP receptor, type I, VIP-R-1, VIP1 receptor, VPAC1 -
Gen-ID
- 7433
-
UniProt
- P32241
Target
-